-
As the market advances, it is advisable to focus on risk management and have a selective approach while looking out for thematic movers amidst the ongoing sectoral rotation, Sameet Chavan said.
-
Nippon Life has seen a breakout of horizontal resistance trendline adjoining highs of June 30 and July 12, and formed a bullish candlestick pattern on the daily timeframe with above average volumes. Further, it has also seen a golden crossover this month.
-
The momentum is expected to take the index up to 19,000 mark in the coming days, with immediate support at 18,800, then 18,700-18,500 area, experts said
-
Chances look bright for the Nifty50 to move towards the record high of 18,604 in the coming days if the momentum sustains and global markets support, with crucial support at the psychological 18,000 mark, said experts. They advise to continue with the 'buy on dips' strategy
-
Redington was also in focus in the falling market, rising nearly 8 percent to Rs 148. The stock has formed robust bullish candle on the daily charts with large volumes after rangebound trade for more than a month.
-
Ajanta Pharma, Alembic Pharma, Astral Poly Tech, AU Small Finance and Bajaj Finance are among the 'potential 25 wealth creators for the next 25 years', the brokerage firm says.
-
One should always avoid investing in bad quality businesses because as is said a rising tide lifts all the boats but the end outcome is always bad in investing if one ignores the quality aspect, Shailendra Kumar of Narnolia advised.
-
The year 2020 is largely about survival, both health-wise and finance-wise. It is also an opportune time to tweak and tighten the portfolio for the next bull run, said Yes Securities
-
Neeraj Chadawar of Axis Securities believes that market volatility is likely to provide good opportunities for Midcaps and Small caps.
-
IT and pharma are preferred themes by experts after June quarter earnings
-
Given that India will remain a growth market in the long-term one cannot neglect growth stocks for a prolonged period of time, Jyoti Roy advised.
-
Experts and analysts expect a change in market leadership in the post-COVID world in which telecom, healthcare, speciality chemicals, and rural consumers may dominate other sectors.
-
This war between USA & China may intensify further & may take ugly shape going forward, which may change World Power Equation post-COVID-19 era, Amit Jain of Ashika Wealth Advisors said.
-
Nifty on March 4 slid almost 200 points during the day but witnessed a sharp recovery in the second half of the session.
-
Vineeta Sharma of Narnolia Financial Advisors also feels results declared so far have been slightly below their estimate.
-
The apt strategy to trade in such a market would be to play the range i.e. buy as close as possible to support and vice versa.
-
Analysts feel investors will still focus on quality stocks only in 2020
-
The rupee's fall is technical in nature and should be viewed in accordance with happenings across the globe.
-
-
Mitessh Thakkar of miteshthacker.com recommends buying HDFC Bank, Lupin, Larsen & Toubro and Delta Corp.
-
Sandeep Wagle of powermywealth.com is of the view that one may hold Alembic Pharmaceuticals.
-
Mitessh Thakkar of miteshthacker.com recommends buying Equitas Holdings, Jet Airways, South Indian Bank, ABB India and Alembic Pharmaceuticals.
-
Mitessh Thakkar of miteshthacker.com suggests selling Adani Enterprises, BEML and Syndicate Bank and advises buying UltraTech Cement and Alembic Pharmaceuticals.
-
In an interview to CNBC-TV18, Ajay Bodke, CEO & Chief Portfolio Manager (PMS) at Prabhudas Lilladher Pvt. Ltd shared his readings and outlook on market, specific stocks and sectors.
-
SP Tulsian, sptulsian.com in an interview to CNBC-TV18 shared his views on stocks like Dish TV, Alembic pharma, sugar stocks, SPARC, Sundaram Finance and others
